Filing Details

Accession Number:
0001127602-12-033702
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-12 16:12:57
Reporting Period:
2012-12-10
Filing Date:
2012-12-12
Accepted Time:
2012-12-12 16:12:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
946840 Viropharma Inc VPHM Pharmaceutical Preparations (2834) 232789550
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1289946 Md Colin Broom 730 Stockton Drive
Exton PA 19341
Vp & Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-12-10 10,000 $5.91 47,667 No 4 M Direct
Common Stock Disposition 2012-12-10 10,000 $24.07 37,667 No 4 S Direct
Common Stock Acquisiton 2012-12-10 50,000 $8.86 87,667 No 4 M Direct
Common Stock Disposition 2012-12-10 50,000 $24.07 37,667 No 4 S Direct
Common Stock Acquisiton 2012-12-10 14,999 $9.96 52,666 No 4 M Direct
Common Stock Disposition 2012-12-10 14,999 $24.07 37,667 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-12-10 10,000 $0.00 10,000 $5.91
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-12-10 50,000 $0.00 50,000 $8.86
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-12-10 14,999 $0.00 14,999 $9.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2010-06-11 2019-06-11 No 4 M Direct
50,000 2011-01-07 2020-01-07 No 4 M Direct
5,001 2009-01-11 2018-01-11 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.22, inclusive.
  2. Includes 97 shares of common stock issued pursuant to the ViroPharma Employee Stock Purchase Plan on June 30, 2012.
  3. The options vest in four equal annual installments beginning on the first anniversary date from time of grant.